Skip to main content
. 2015 Aug 18;15:591. doi: 10.1186/s12885-015-1583-4

Fig. 1.

Fig. 1

Inclusion of main chemotherapeutic and hormonal therapy regimens in NEMLs (n = 75). CMF: cyclophosphamide, methotrexate and fluorouracil; CAF: cyclophosphamide, doxorubicin (adriamycin), fluorouracil, AC: doxorubicin and cyclophosphamide; EC: epirubicine and cyclophosphamide; CEF: cyclophosphamide, epirubicine and fluorouracil; DCa: docetaxel and carboplatin; DC: docetaxel and cyclophosphamide; AIs: Aromatase Inhibitors